On 01 July 2011 the EMA announced that the EudraVigilance Medicinal Product Dictionary (EVMPD) – will become mandatory on 2 July 2012. It has been rebranded and called XEVMPD- Extended EudraVigilance Medicinal Product Dictionary.
Regulis has been closely following the developments of XEVMPD and has a team that has acquired accreditation for the Web Trader tool and has a number of years’ experience in Pharmacovigilance. We are in a strong position to offer you a tailored XEVMPD service.
Regulis has a dual approach, depending on your size and future requirements.
WEB Trader – WEB Trader tool will suit small scale requirements, however, to use the WEB Trader EVWeb tool, you must successfully receive accreditation on the use of the tool. Regulis has accredited personnel and access to use it.
Vendor Tool – Medium to large scale requirements will be managed using a software tool, this maximises efficiency for the client. We have the software to be able to manage this on your behalf.
We understand that each client is different and we are happy to discuss our flexible service on a one to one basis, our service offering on XEVMPD, in anticipation of the deadline of July 2012 as well as the longer term Life Cycle Management through to ISO integration in 2015.
- Experienced team
- Practically trained
- Ready to start
- Flexible pricing
For more information on Regulis‘s XEVMPD Solutions, please contact us.